Director Oetgen bought 25,000 shares of ARXS at $28.00 ($700.0K); part of 6-insider cluster buy pattern post-IPO.
Stephen Duane Oetgen, a Director at Arxis, Inc., purchased 25,000 shares at $28.00 on 2026-04-17, increasing his holdings from 5,357 shares to 30,357 shares (+466.7% vs pre-transaction holdings). The transaction occurred just 3 trading days after the stock's recent listing. This purchase is part of a cluster pattern: 6 other insiders also bought within the past 14 days, suggesting synchronized board or management-level accumulation immediately following the IPO. The stock has since moved to $37.65 as of 2026-04-20, but meaningful performance context is limited given the very recent listing. The coordinated buying pattern across multiple insiders in the immediate post-IPO window merits attention as an indicator of insider confidence at the IPO pricing level.